Companies / Singapore
GSK Looks To India, Singapore
November 2006 | Company Finance AlertUK-based drugmaker GlaxoSmithKline (GSK) has indicated that in future it will be conducting more of its R&D in Asia, with Singapore and India looking like the company's favoured locations. The company expects to have an Indian-originated compound on the market within five years.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
